Statement Of Cash Flows [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for decrease (increase) in trade and other receivables |
4,503,000
USD
|
1,554,000
USD
|
| Adjustments for increase (decrease) in trade and other payables |
7,290,000
USD
|
2,011,000
USD
|
| Adjustments for decrease (increase) in other current assets |
1,777,000
USD
|
1,821,000
USD
|
| Adjustments for decrease (increase) in biological assets |
3,384,000
USD
|
12,209,000
USD
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories |
1,159,000
USD
|
243,000
USD
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
4,057,000
USD
|
14,095,000
USD
|
| Cash flows from (used in) financing activities [abstract] | ||
| Proceeds from issue of bonds, notes and debentures |
20,000,000
USD
|
-
USD
|